Partnering Webinars

  1. Top 3 Tips For Choosing The Right Oncology CRO 5/14/2025

    From complex study designs and evolving regulations to time-sensitive treatment protocols, advancing oncology clinical trials present significant challenges for investigators, sites, and patients.

  2. APAC's Advantage In Oncology Trials: Fast Start, Lower Cost, Global Impact 5/14/2025

    Partnering with Southern Star Research provides access to deep regional expertise, operational excellence, and a proven track record of delivering high-quality clinical trials.

  3. Navigating The Early Oncology Landscape: Market Trends And Insights 5/14/2025

    Explore the evolving landscape of early-phase oncology clinical trials, including strategic insights to empower operations teams in optimizing study design, site selection, and recruitment.

  4. Strategic Considerations For Oncology Trials In A Competitive Landscape 5/14/2025

    By combining strategic foresight with hands-on support, the right partner accelerates oncology trial delivery and broadens access to promising therapies.

  5. Early Oncology Clinical Trials: Key Considerations To Plan For Success 5/14/2025

    This presentation outlines the key success factors driving high-impact oncology drug development, with a focus on translating innovative science into clinically and commercially meaningful outcomes.

  6. The Importance Of Cognitive And Pharmacodynamic Testing During FIH Trials 5/9/2025

    Learn how to identify which cognitive and pharmacodynamic tests are required for novel CNS-active drugs and best practices on conducting them during First-In-Human (FIH) trials.

  7. How To Drive Stronger Sponsor-Site Partnerships 4/25/2025

    Karri Venn of SCRS discussed the value of deep partnerships, referencing a Sanofi initiative (SMILE) that trusted sites with protocol input and offered maximum budgets without negotiation.

  8. How Sites Are Often Evaluated By Sponsors 4/25/2025

    Adam Kinsey described how sponsor-site partnerships at Merck typically start small. Sites are evaluated not only on enrollment but on predictability and communication throughout a study.

  9. Why Relationship-Building Is The Hardest Part Of Site Success 4/25/2025

    Site owner Devora Henderson of Elevate Clinical Research reflected on her experience launching two site networks.

  10. How Merck Enhances Site Collaboration 4/25/2025

    Learn about Merck’s approach to fostering strong site relationships through specialty roles like institutional lead CRAs and site relationship managers.